Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics N.V (PRQR) Non-Current Deffered Revenue: 2021-2025

Historic Non-Current Deffered Revenue for ProQR Therapeutics N.V (PRQR) over the last 5 years, with Sep 2025 value amounting to $28,203.

  • ProQR Therapeutics N.V's Non-Current Deffered Revenue fell 16.42% to $28,203 in Q3 2025 from the same period last year, while for Sep 2025 it was $28,203, marking a year-over-year decrease of 16.42%. This contributed to the annual value of $31.4 million for FY2024, which is 34.18% down from last year.
  • ProQR Therapeutics N.V's Non-Current Deffered Revenue amounted to $28,203 in Q3 2025, which was down 7.67% from $30,546 recorded in Q2 2025.
  • In the past 5 years, ProQR Therapeutics N.V's Non-Current Deffered Revenue registered a high of $69.6 million during Q1 2023, and its lowest value of $687.55 during Q1 2021.
  • Moreover, its 3-year median value for Non-Current Deffered Revenue was $37,519 (2024), whereas its average is $21.3 million.
  • As far as peak fluctuations go, ProQR Therapeutics N.V's Non-Current Deffered Revenue spiked by 2,211,913.24% in 2022, and later plummeted by 99.94% in 2024.
  • ProQR Therapeutics N.V's Non-Current Deffered Revenue (Quarterly) stood at $16.8 million in 2021, then surged by 298.15% to $66.9 million in 2022, then declined by 28.96% to $47.5 million in 2023, then plummeted by 99.93% to $31,448 in 2024, then fell by 16.42% to $28,203 in 2025.
  • Its last three reported values are $28,203 in Q3 2025, $30,546 for Q2 2025, and $29,767 during Q1 2025.